Prosecution Statements Rear Their Ugly Head By Adriana L. Burgy Stacy Lewis on June 16, 2023 Email this postTweet this postLike this postShare this post on LinkedIn In Azurity Pharms., Inc. v. Alkem Labs. Ltd., 2023 U.S. Dist. LEXIS 77839 (D. Del. May 4, 2023), the district court held that Azurity failed to show that Alkem’s ANDA infringed the asserted claims. Read more
